Leaflet: information for the user
Linitul Antiseptic 10 mg/ml skin spray solution
Read this leaflet carefully before you start using this medicine, because it contains important information for you.
Follow exactly the administration instructions for the medicine contained in this leaflet or those indicated by your doctor or pharmacist.
Linitul Antiséptico10 mg/ml is a topical medication whose active ingredient is chlorhexidine digluconate.
It is indicated as a wound and minor skin burn antiseptic and as umbilical cord antiseptic in newborns.
Consult a doctor if it worsens or does not improve after 5 days.
No use Linitul Antiséptico 10 mg/ml
Warnings and Precautions
Consult your doctor or pharmacist before starting to use this medication.
Severe cases of persistent corneal injury (injury to the surface of the eye) have been reported, which may require a corneal transplant when similar products have accidentally entered the eyes during surgical procedures, in patients under general anesthesia (deep, painless sleep).
Children
Use of Linitul Antiséptico 10 mg/ml with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
The excretion of chlorhexidine or any of its metabolites in breast milk is unknown. The possible risk of systemic effects should be taken into account.
Driving and operating machinery
The influence of this medication on the ability to drive or operate machinery is negligible or insignificant.
Follow exactly the administration instructions of the medication contained in this leaflet or those indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
Do not dilute this medication. It is recommended to clean and dry the wound before applying this medication. Apply to the affected area, or on a gauze, one or two times a day. Do not perform more than two daily applications of the product.
If you use more Linitul Antiséptico 10 mg/ml than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Information for the healthcare professional
In case of accidental ingestion, proceed with gastric lavage and protection of the digestive mucosa.
Cases of hemolysis have been described after ingestion of chlorhexidine. In case of hemolysis, blood transfusion may be necessary.
Like all medications, this medication may produce adverse effects, although not all people may experience them.
The following adverse effects may occur (frequency unknown: cannot be estimated from available data):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Usehttp://www.notificaram.es.By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
This medication does not require special preservation conditions.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Dispose of the packaging after 6 months of its first opening, even if it is not empty. Do not store for future use.
Medicines should not be thrown down the drains or in the trash. Deposit the packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Linitul Antiséptico 10 mg/ml
Additional information
Appearance of the product and contents of the packaging
Transparent, colorless, or slightly yellowish solution presented in high-density polyethylene bottles, equipped with 25 ml and 100 ml spray pumps, and clinical containers of 20 bottles of 100 ml and 250 ml.
Holder of the marketing authorization and responsible manufacturer
Holder:
ALFASIGMA ESPAÑA, S.L.
Avda. Diagonal 490
08006 Barcelona
Responsible manufacturer:
LAINCO, S.A.
Avda. Bizet, 8-12
08191 RUBÍ - Barcelona (Spain)
Date of the last review of this leaflet: October 2024
The updated and detailed information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.